ChromaDex Corporation Reports 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
ChromaDex (CDXC) Misses Q4 EPS by 1c
March 10, 2021 4:26 PM ESTChromaDex (NASDAQ: CDXC) reported Q4 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $15.4 million versus the consensus estimate of $15.36 million.
Fourth Quarter 2020 and Recent Highlights
Total net sales of $15.4 million, up 18% from $13.1 million in the year ago quarter.Tru Niagen® net sales of $12.3 million, a 21% increase from the year ago quarter.Gross margin of 61.0%, a 400 basis point increase from the year ago quarter.Net loss was ($6.1) million or ($0.10) per share,... More